Indigenously developed Covaxin has got emergency use authorisation approval. It marks a momentous day in the history of the Indian vaccine industry. Covaxin is the first vaccine to be developed from scratch in India. Right from the virus strain being isolated from an Indian patient by the Indian Council of Medical Research-National Institute of Virology Pune, to the formulation, animal studies and human trials, everything has been done locally. An ecstatic Bharat Biotech founder chairman and managing director Dr Krishna Ella termed it as a dream moment for Indian science. “It’s an achievement of the young generation scientists of the country,” he said.